{"transactions":[{"id":3479327,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-25T15:40:28.000Z","date":"2019-06-21","kind":"purchase","acquired":true,"shares":2481,"price":4.03,"value":9998.43,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Previous Balance of the amount of Securities Owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019."}],"balance_after":5420,"source":{"system":"sec-edgar","filing":"0001702626-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000170262619000005/primary_doc.xml","form_type":"4"}},{"id":3488451,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-17T18:58:03.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares."}],"balance_after":129304,"source":{"system":"sec-edgar","filing":"0001613377-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337719000004/primary_doc.xml","form_type":"4"}},{"id":3488450,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-17T18:58:03.000Z","date":"2019-03-25","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued."}],"balance_after":94304,"source":{"system":"sec-edgar","filing":"0001613377-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337719000004/primary_doc.xml","form_type":"4"}},{"id":3598181,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Subr Rights(to buy)","published_at":"2019-03-13T16:51:37.000Z","date":"2019-03-04","kind":"other","acquired":true,"shares":10,"price":1000,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants."}],"balance_after":0,"derivative":{"exercise_price":1000,"exercise_date":"2019-02-14","expiration_date":"2019-03-05","underlying":"Pref Stk/Warrants"},"source":{"system":"sec-edgar","filing":"0001583701-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946644/000158370119000002/primary_doc.xml","form_type":"4"}},{"id":3598180,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Warrants","published_at":"2019-03-13T16:51:37.000Z","date":"2019-03-04","kind":"other","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001583701-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946644/000158370119000002/primary_doc.xml","form_type":"4"}},{"id":3598179,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-03-13T16:51:37.000Z","date":"2019-03-04","kind":"other","acquired":true,"shares":10,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants."}],"balance_after":10,"source":{"system":"sec-edgar","filing":"0001583701-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000158370119000002/primary_doc.xml","form_type":"4"}},{"id":3682860,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Options to buy Common Stock","published_at":"2019-01-30T16:36:37.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":184659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management for a voluntary 50% deferral in salary."}],"balance_after":184659,"derivative":{"exercise_price":0.22,"exercise_date":"2019-01-28","expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":184659},"source":{"system":"sec-edgar","filing":"0001450324-19-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000145032419000005/primary_doc.xml","form_type":"4"}},{"id":3749642,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2018-11-29T15:11:55.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019."}],"balance_after":44304,"source":{"system":"sec-edgar","filing":"0001613377-18-000035","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000035/primary_doc.xml","form_type":"4"}},{"id":3762004,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Options to buy Common Stock","published_at":"2018-11-16T16:55:13.000Z","date":"2018-11-14","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option has been awarded by the Board of Directors."}],"balance_after":1000,"derivative":{"exercise_price":0.22,"exercise_date":"2018-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001613377-18-000031","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000031/primary_doc.xml","form_type":"4"}},{"id":3787183,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Options to buy Common Stock","published_at":"2018-10-19T15:24:39.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":123106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being issued to senior management in exchange for a voluntary 50% deferral in salary."}],"balance_after":123106,"derivative":{"exercise_price":0.22,"exercise_date":"2018-10-17","expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":123106},"source":{"system":"sec-edgar","filing":"0001613377-18-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337718000022/primary_doc.xml","form_type":"4"}},{"id":3960355,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Options to buy Common Stock","published_at":"2018-04-19T17:46:05.000Z","date":"2018-04-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option is being awarded by the Board of Directors."}],"balance_after":75000,"derivative":{"exercise_price":0.38,"exercise_date":"2018-04-12","expiration_date":"2028-04-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001465652-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000146565218000004/primary_doc.xml","form_type":"4"}},{"id":4338708,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-02T18:31:30.000Z","date":"2017-05-02","kind":"purchase","acquired":true,"shares":7937,"price":0.63,"value":5000.31,"ownership":{"direct":true},"balance_after":41804,"source":{"system":"sec-edgar","filing":"0001613377-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000006/primary_doc.xml","form_type":"4"}},{"id":4437216,"issuer":{"id":8131,"kind":"organization","name":"AIM ImmunoTech Inc.","symbol":"AIM"},"owners":[{"id":156493,"kind":"person","name":"STRAYER DAVID R","position":1,"cik":"0001270074","reported_name":"STRAYER DAVID R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science/Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-21T19:15:48.000Z","date":"2017-02-16","kind":"purchase","acquired":true,"shares":9892,"price":0.46,"value":4550.32,"ownership":{"direct":true},"balance_after":33867,"source":{"system":"sec-edgar","filing":"0001613377-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946644/000161337717000003/primary_doc.xml","form_type":"4"}}]}